Answers are grounded in this paper and cite their sources.
Development of ARDS may play a role in estimating disease progression and mortality risk. Early detection of elevations in serum CRP, combined with a clinical COVID-19 symptom presentation may be used as a surrogate marker for the presence and severity of the disease. There is a paucity of data surrounding the efficacy of treatments. There is currently not a well-established gold standard therapy for the treatment of diagnosed COVID-19. Further prospective investigations are necessary.
No takes yet. Share an insight, caveat, or question.
Tahvildari et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: